Premenopausal node-negative breast cancer: May adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?

By Wyss-desserich M-T.  

Breast Cancer Research and Treatment, Vol. 42, Iss. 3, 1997-02 ,pp. : 253-263

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory cells in node-negative breast cancer

By Löfdahl Britta   Ahlin Cecilia   Holmqvist Marit   Holmberg Lars   Zhou Wenjing   Fjällskog Marie-Louise   Amini Rose-Marie  

Acta Oncologica, Vol. 51, Iss. 5, 2012-05 ,pp. : 680-686

Informa Healthcare

Access to resources Recommend Favorite

Prognostic variables in node-negative and node-positive breast cancer - Introduction

By Gasparini G.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 193-194

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer

By Jakesz R.   Hausmaninger H.   Samonigg H.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

By Land Stephanie   Kopec Jacek   Yothers Greg   Anderson Stewart   Day Richard   Tang Gong   Ganz Patricia   Fisher Bernard   Wolmark Norman  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 153-164

Springer Publishing Company

Access to resources Recommend Favorite